4D Molecular Therapeutics, Inc. (FDMT) - Pendapatan perusahaan

4D Molecular Therapeutics, Inc. (FDMT) - logo korporat

The high margin potential of 4D Molecular Therapeutics (FDMT) is based on cutting-edge IT developments in the field of DNA vector maturation. The company's gross sales volume trend visualizes the intensity of demand, where 0.10 represents the current metric. Despite fierce competition with pharma behemoths for investment, the massive deferred demand for macular dystrophy treatment paves the way for a large-scale expansion of the customer base.

4D Molecular Corp (FDMT): Pendapatan lan volume dodolan saka 04.07.2022 nganti 17.11.2026

FDMT (4D Molecular Corp): rincian analitis lan laporan miturut indikator

Analisis dhasar perusahaan:FDMT, 4dmoleculartherapeutics.com
Produk mawa merek 4D Molecular Therapeutics Inc

Investors are searching 4D Molecular Therapeutics (FDMT) financial reports for sustainable fundamental benchmarks to assess business value. This metric captures daily operational cash flow without time lags. Analyzing the volume of products sold by 4D Molecular Therapeutics (FDMT) allows for the timely detection of revenue declines and prevents purchasing the asset at its peak. For this biopharmaceutical pioneer in gene therapy, such a metric confirms the commercial demand for its DNA vector IT platform. Monitoring revenue objectifies the company's scientific potential through the lens of actual market inflows.

Analisis pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Volume dodolan perusahaan|Pendapatan perusahaan Solid Biosciences SLDB|OCGN - Dodolan perusahaan|pacb.com - Pendapatan lan volume dodolan|Benitec (BNTC) - Dodolan perusahaan|DSGN: Pendapatan lan volume dodolan|RCKT - Pendapatan reged perusahaan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan